MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
542.35%
Quick Ratio
295.11%
Cash Ratio
113.76%
Debt to Asset Ratio
69.43%
Unit: Thousand (K) dollars
Assets Breakdown
Intangible assets, net
Cash and cash equivalents
Prepaid expenses and other curre...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost, 10.7 an...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
139,700
160,300
205,400
245,500
Restricted cash
1,200
1,200
3,700
3,700
Accounts receivable, net
190,000
121,600
84,200
149,500
Inventories, net
303,600
327,600
343,400
356,300
Prepaid expenses and other current assets
25,400
26,900
25,800
25,600
Assets held-for-sale
6,100
-
-
6,300
Total current assets
666,000
637,600
662,500
786,900
Property, plant and equipment, net
178,000
199,400
205,400
209,800
Intangible assets, net
261,800
470,400
436,500
452,700
Other assets
11,000
13,000
14,200
11,600
Total assets
1,116,800
1,320,400
1,318,600
1,461,000
Accounts payable
50,200
39,500
55,600
57,400
Accrued expenses
17,100
9,400
12,200
13,900
Accrued compensation
26,200
22,000
41,800
36,600
Accrued acquisition obligation
-
50,400
-
-
Deferred revenue
15,000
12,200
-
-
Current tax liability
4,400
7,200
6,800
-
Other current liabilities
9,900
8,000
15,800
24,100
Liabilities held for sale
-
-
-
4,500
Total current liabilities
122,800
148,700
132,200
136,500
Debt
581,800
573,600
572,100
663,100
Deferred tax liability
35,400
33,300
37,800
36,300
Other liabilities
35,400
41,700
53,900
42,600
Total liabilities
775,400
797,300
796,000
878,500
Common stock, 0.001 par value per share 200.0 shares authorized, 61.9 and 60.9 shares issued 51.3 and 52.1 shares outstanding, respectively
100
100
100
100
Treasury stock, at cost, 10.7 and 8.7 common shares, respectively
270,500
261,600
252,600
243,500
Additional paid-in capital
951,800
944,500
942,400
938,600
Accumulated other comprehensive loss, net
-6,800
-6,900
-7,500
-7,500
Accumulated deficit
-333,200
-153,000
-159,800
-105,200
Total stockholders equity
341,400
523,100
522,600
582,500
Total liabilities and stockholders equity
1,116,800
1,320,400
1,318,600
1,461,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Inventories, net
$303,600K
(-10.34%↓ Y/Y)
Accounts receivable, net
$190,000K
(138.10%↑ Y/Y)
Cash and cash
equivalents
$139,700K
(-47.74%↓ Y/Y)
Prepaid expenses and
other current assets
$25,400K
(5.83%↑ Y/Y)
Assets held-for-sale
$6,100K
(0.00%↑ Y/Y)
Restricted cash
$1,200K
(-67.57%↓ Y/Y)
Total current assets
$666,000K
(-7.44%↓ Y/Y)
Intangible assets, net
$261,800K
(-44.18%↓ Y/Y)
Property, plant and
equipment, net
$178,000K
(-17.63%↓ Y/Y)
Other assets
$11,000K
(-12.00%↓ Y/Y)
Total assets
$1,116,800K
(-21.19%↓ Y/Y)
Total liabilities and
stockholders equity
$1,116,800K
(-21.19%↓ Y/Y)
Total liabilities
$775,400K
(-11.98%↓ Y/Y)
Total stockholders
equity
$341,400K
(-36.33%↓ Y/Y)
Accumulated deficit
-$333,200K
(-113.04%↓ Y/Y)
Treasury stock, at cost,
10.7 and 8.7 common...
$270,500K
(15.30%↑ Y/Y)
Accumulated other
comprehensive loss, net
-$6,800K
(16.05%↑ Y/Y)
Debt
$581,800K
(-12.88%↓ Y/Y)
Total current
liabilities
$122,800K
(-3.38%↓ Y/Y)
Other liabilities
$35,400K
(-10.38%↓ Y/Y)
Deferred tax liability
$35,400K
(-23.87%↓ Y/Y)
Additional paid-in capital
$951,800K
(1.78%↑ Y/Y)
Common stock, 0.001 par
value per share 200.0...
$100K
(0.00%↑ Y/Y)
Accounts payable
$50,200K
(-21.19%↓ Y/Y)
Accrued compensation
$26,200K
(-16.83%↓ Y/Y)
Accrued expenses
$17,100K
(25.74%↑ Y/Y)
Deferred revenue
$15,000K
Other current
liabilities
$9,900K
(-27.21%↓ Y/Y)
Current tax liability
$4,400K
Buy us a coffee
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)